JGO Weekly Summary (February 18, 2025)

JGO Weekly Summary (February 18, 2025)

This episode of the Journal of Gynecologic Oncology podcast explores a study by Berthet and colleagues on the role of platinum-free interval in predicting the benefit of second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma. Analyzing a retrospective cohort of 40 patients, the study found that patients with a progression-free survival of more than nine months had a significantly longer overall survival after relapse when treated with platinum- or anthracycline-based chemotherapy. In contrast, those with earlier recurrence derived little benefit from additional chemotherapy, with outcomes comparable to patients receiving only best supportive care. These findings suggest that platinum-free interval could serve as a useful marker to guide treatment decisions. Tune in for a discussion on the clinical implications, potential therapeutic targets, and the future of individualized treatment strategies in gynecologic carcinosarcoma.


Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

JGO Weekly Summary (July 6, 2025)

JGO Weekly Summary (July 6, 2025)

This episode summarizes a cross-sectional study from Central China on HPV genotype distribution and infection risk factors. Ye Chen and colleagues found that HPV52, 16, and 58 were most common, with i...

6 Heinä 20254min

JGO Weekly Summary (May 11, 2025)

JGO Weekly Summary (May 11, 2025)

In this episode of the JGO Podcast, we explore a recent study from Peking Union Medical College Hospital examining the role of adjuvant surgery in patients with high-risk chemorefractory or relapsed g...

11 Touko 20254min

JGO Weekly Summary (April 29, 2025)

JGO Weekly Summary (April 29, 2025)

This episode features an in-depth discussion of the Asian cohort analysis from the AtTEnd/ENGOT-EN7 phase III trial, which evaluated atezolizumab in combination with carboplatin and paclitaxel for adv...

1 Touko 20255min

JGO Weekly Summary (April 22, 2025)

JGO Weekly Summary (April 22, 2025)

In this episode, we review findings from the Japan subset of the DUO-E phase III trial, led by Shin Nishio and colleagues, which evaluated durvalumab with or without olaparib following chemotherapy in...

22 Huhti 20254min

JGO Weekly Summary (April 10, 2025)

JGO Weekly Summary (April 10, 2025)

In this episode, we discuss the final analysis of the KEYNOTE-826 subgroup study led by Dr. Yong-Man Kim, evaluating pembrolizumab plus chemotherapy with or without bevacizumab in East Asian patients ...

10 Huhti 20255min

JGO Weekly Summary (March 25, 2025)

JGO Weekly Summary (March 25, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we review a recent meta-analysis by Tianyu Zhang and colleagues titled "Role of Adjuvant Chemotherapy in Stage IC Ovarian Granulosa Cell...

26 Maalis 20255min

JGO Weekly Summary (March 18, 2025)

JGO Weekly Summary (March 18, 2025)

In this episode of the Journal of Gynecologic Oncology podcast, we discuss a study by Baldwin and colleagues titled Evaluation of the Role of Liver Metastasectomy in the Treatment of Stage IV Endometr...

19 Maalis 20254min

JGO Weekly Summary (March 11, 2025)

JGO Weekly Summary (March 11, 2025)

This episode explores a recent study on the increased risk of cardiovascular disease among adolescent and young adult survivors of cervical cancer. Using data from the Korean National Health Insurance...

11 Maalis 20255min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-pitaisko-erota
meditaatiot-suomeksi
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-kuumilla-aalloilla
rss-seksicast
katilon-kahvitunti
paritellen
junnut-pelissa
rss-uplevel-by-sonja-hannus
rss-narsisti
terapiassa
rss-pt-paahtio
rss-ehjaksi
rss-mighty-finland-podcast
traumapodi
rss-nautinto